Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world in our monthly bulletin and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world in our monthly bulletin and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Catch up with all our news stories and summary bulletins on aidsmap.com
www.aidsmap.com/conferences/...
Catch up with all our news stories and summary bulletins on aidsmap.com
www.aidsmap.com/conferences/...
-Does 6-monthly PrEP have a future after funding collapse?
-HIV integration sparks fierce debate
-US funding cuts & HIV testing/treatment
-Antibodies shows promise in the search for a cure
www.aidsmap.com/bulletin/con... @iasociety.bsky.social
-Does 6-monthly PrEP have a future after funding collapse?
-HIV integration sparks fierce debate
-US funding cuts & HIV testing/treatment
-Antibodies shows promise in the search for a cure
www.aidsmap.com/bulletin/con... @iasociety.bsky.social
-Monthly oral PrEP pill
-Injectable ART works for people with adherence challenges
-ART switches don't reduce weight
-PEPFAR cuts & PrEP
www.aidsmap.com/bulletin/con...
@iasociety.bsky.social
-Monthly oral PrEP pill
-Injectable ART works for people with adherence challenges
-ART switches don't reduce weight
-PEPFAR cuts & PrEP
www.aidsmap.com/bulletin/con...
@iasociety.bsky.social
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
https://www.aidsmap.com/subscribe
-HIV funding crisis the focus of #IAS2025
-DoxyPEP faces resistance challenges
-Rwanda showcases HIV success
-Engineered T-cells selectively kill HIV reservoir cells in mice
www.aidsmap.com/bulletin/con...
-HIV funding crisis the focus of #IAS2025
-DoxyPEP faces resistance challenges
-Rwanda showcases HIV success
-Engineered T-cells selectively kill HIV reservoir cells in mice
www.aidsmap.com/bulletin/con...
https://www.aidsmap.com/subscribe @iasociety.bsky.social
https://www.aidsmap.com/subscribe @iasociety.bsky.social
An elite controller is a person living with HIV who is able to maintain undetectable viral loads for at least 12 months despite not having started HIV treatment. www.aidsmap.com/about-hiv/fa...
An elite controller is a person living with HIV who is able to maintain undetectable viral loads for at least 12 months despite not having started HIV treatment. www.aidsmap.com/about-hiv/fa...
https://www.aidsmap.com/about-hiv/faq/whats-difference-between-prep-and-pep-hiv-prevention
https://www.aidsmap.com/about-hiv/faq/whats-difference-between-prep-and-pep-hiv-prevention
Subscribe to aidsmap bulletins and you'll receive our bulletins from international HIV conferences, sharing HIV research and developments.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and you'll receive our bulletins from international HIV conferences, sharing HIV research and developments.
https://www.aidsmap.com/subscribe
https://bit.ly/45Lj7Xk #IAS2025
https://bit.ly/45Lj7Xk #IAS2025
Subscribe to aidsmap bulletins and you'll receive our bulletins from international HIV conferences, sharing HIV research and developments.
https://www.aidsmap.com/subscribe
Subscribe to aidsmap bulletins and you'll receive our bulletins from international HIV conferences, sharing HIV research and developments.
https://www.aidsmap.com/subscribe
https://www.aidsmap.com/news/apr-2025/manufacturers-plans-equitable-access-twice-yearly-prep-under-fire
#PrEP #HIV #lenacapavir
https://www.aidsmap.com/news/apr-2025/manufacturers-plans-equitable-access-twice-yearly-prep-under-fire
#PrEP #HIV #lenacapavir
-Coronary artery disease in Uganda
-Statins & heart health
-HIV testing requirements & inj PrEP
-Low doxyPEP uptake among HIV+ people
-Simplified PrEP monitoring as effective as standard care
www.aidsmap.com/bulletin/conference-news/croi-2025/21-march-2025
-Coronary artery disease in Uganda
-Statins & heart health
-HIV testing requirements & inj PrEP
-Low doxyPEP uptake among HIV+ people
-Simplified PrEP monitoring as effective as standard care
www.aidsmap.com/bulletin/conference-news/croi-2025/21-march-2025
CROI 2025: US funding freeze threatens two decades' progress in HIV, 13 March 2025 https://www.aidsmap.com/bulletin/conference-news/croi-2025/13-march-2025
CROI 2025: US funding freeze threatens two decades' progress in HIV, 13 March 2025 https://www.aidsmap.com/bulletin/conference-news/croi-2025/13-march-2025